Danaparoid and upper gastrointestinal haemorrhage Patient Reports February 13, 2012

Danaparoid Side Effects Report #5077936-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 02, 2006. Male patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, condition aggravated, haemoglobin decreased, platelet count increased, upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with MICAFUNGIN, METHYLPREDNISOLONE SUCCINATE, PLATELETS, PLASMA PROTEIN FRACTION, CARBENIN. Patient died.

Danaparoid Side Effects Report #5118898-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 19, 2006. Female patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood urea increased, condition aggravated, haemoglobin decreased, pneumonia , upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with DORIPENEM HYDRATE, ROXATIDINE ACETATE. Patient died.

Danaparoid Side Effects Report #4975616-4
Danaparoid side effect was reported by a Health Professional from JAPAN on Dec 27, 2005. Male patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, haemoglobin decreased, infection , upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with MICAFUNGIN, METHYLPREDNISOLONE SUCCINATE, PLATELETS, PLASMA PROTEIN FRACTION, CARBENIN. Patient died on 01/21/2005.

Danaparoid Side Effects Report #4976159-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Dec 27, 2005. Male patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neoplasm malignant, upper gastrointestinal haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with AMINOLEBAN, OMEPRAZOLE, GABEXATE MESILATE, ULINASTATIN, IMMUNE GLOBULIN INTRAVENOUS, BICARBONATE, FUROSEMIDE. Patient died.


Danaparoid Side Effects Report #5006923-7
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on May 09, 2006. Female patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haemoglobin decreased, pneumonia , upper gastrointestinal haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with DORIPENEM HYDRATE, ROXATIDINE ACETATE. Patient died.

Danaparoid Side Effects Report #5027820-7
Danaparoid side effect was reported by a Health Professional from JAPAN on June 05, 2006. Male patient, 82 years of age, was diagnosed with disseminated intravascular coagulation, pulmonary mycosis, shock, pneumonia  and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, haemoglobin decreased, upper gastrointestinal haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with MICAFUNGIN, METHYLPREDNISOLONE SUCCINATE, PLATELETS, PLASMA PROTEIN FRACTION, CARBENIN. Patient died.

Danaparoid Side Effects Report #5027821-9
Danaparoid side effect was reported by a Health Professional from JAPAN on June 05, 2006. Male patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haemoglobin decreased, upper gastrointestinal haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with AMINOLEBAN, OMEPRAZOLE, GABEXATE MESILATE, ULINASTATIN, IMMUNE GLOBULIN INTRAVENOUS, BICARBONATE, FUROSEMIDE. Patient died.

Danaparoid Side Effects Report #5046810-1
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 23, 2006. Female patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, haemoglobin decreased, hepatic function abnormal, pneumonia , renal impairment, upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with DORIPENEM HYDRATE, ROXATIDINE ACETATE. Patient died.

Danaparoid Side Effects Report #5063640-5
Danaparoid side effect was reported by a Physician from JAPAN on July 06, 2006. Male patient, 56 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood creatinine increased, blood urea increased, condition aggravated, haemoglobin decreased, upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with NAFAMOSTAT MESILATE, ANTITHROMBIN III, FAMOTIDINE. Patient died.